Novel role for CD163 in ozone induced alterations of pulmonary immunity
CD163 在臭氧诱导的肺免疫改变中的新作用
基本信息
- 批准号:10170356
- 负责人:
- 金额:$ 60.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAffectAir PollutantsAir PollutionAlveolar MacrophagesAnti-Inflammatory AgentsApoptoticAreaBacterial TranslocationBiologicalBiological AssayBiological MarkersBronchoalveolar LavageBronchoalveolar Lavage FluidBronchoscopyCell surfaceCellsChronicClear CellCleaved cellComplexDataDevelopmentEmergency SituationEnvironmental PollutantsEpidemiologyExposure toFamilyFrequenciesHealthHemeHemoglobinHemoglobin concentration resultHospitalizationHost DefenseHourHumanImmunityImpairmentIncidenceInfectionInflammationInflammatoryInflammatory ResponseInjuryKlebsiella pneumoniaeKnowledgeLaboratoriesLinkLungLung InflammationLung diseasesLung infectionsMediatingMediator of activation proteinMembraneMolecularMusNeutrophiliaOrganOxidesOzonePathway interactionsPhagocytosisPneumococcal InfectionsPopulationPredispositionPublic HealthPulmonary InflammationResearchResolutionRespiratory Tract InfectionsRoleSR-B proteinsSamplingSchoolsTherapeuticTherapeutic EffectTranslatingUnited StatesVisitair filterbaseepidemiology studyhaptoglobin-hemoglobin complexheme oxygenase-1human datahuman subjectimprovedin vivolung injurymacrophagemonocytemouse modelneutrophilnovelozone exposurepathogenpollutantreceptorrespiratory pathogenresponsescavenger receptortherapeutic evaluation
项目摘要
Ozone (O3) causes lung injury, exacerbates chronic pulmonary diseases, and increases susceptibility to respiratory
infections. Epidemiological studies strongly associate air pollution exposures and incidence of respiratory
infections, which is important since more than 1/3 of the United States population lives in areas exceeding the
current O3 regulatory standards. Though O3 exposure clearly impairs pulmonary host defense, the specific
molecular mechanisms enhancing respiratory pathogen susceptibility remain poorly understood. Defining these
mechanisms requires linking molecular pathways modified by environmental pollutants to those critical to host-
pathogen interactions. The scavenger receptor families are such a molecular pathway. In this proposal, we plan to
study the scavenger receptor CD163 in O3-induced alterations of pulmonary immunity. CD163 is a class B
scavenger receptor, expressed on monocytes and macrophages, which exists in both membrane-bound and
soluble (sCD163) forms. Membrane CD163 clears cell-free hemoglobin (CFH) by recognizing and internalizing
hemoglobin-haptoglobin complexes. Once recognized by CD163, the complex is degraded by heme-oxygenase-1
into anti-inflammatory byproducts. Delayed CFH clearance augments inflammatory responses, exacerbates lung
diseases, and modifies macrophage phagocytosis and apoptotic cell clearance (efferocytosis) resulting in
persistent inflammation and defective pathogen clearance. Defining the role of CD163 in O3-mediated macrophage
functions could uncover a novel mechanism mediating O3-induced adverse health effects. Our preliminary studies
indicate that CD163 expression is upregulated in bronchoalveolar lavage (BAL) macrophages from human subjects
undergoing acute laboratory O3 exposure. Supporting the human data, mice exposed to O3 have increased BAL
macrophage CD163 expression and BALF CFH. O3-exposed CD163 deficient mice demonstrate increased lung
injury, neutrophilia and frequency of airspace apoptotic neutrophils. On the basis of these observations, we
hypothesize that macrophage-dependent clearance of CFH is mediated by CD163, a mechanism that limits
acute lung injury after O3, and maintains effective efferocytosis and pathogen phagocytosis. The studies
proposed will define: 1) how CD163 limits pulmonary inflammation by promoting efferocytosis; and 2) how CD163
clearance of CFH maintains macrophage phagocytosis of pathogens. These studies are translational; integrating
murine and human samples/observations. Completion of these studies would define a novel molecular pathway for
O3-induced health effects and define a specific mechanism by which ambient pollutants mediate critical
macrophage functions. Furthermore, studies with sCD163 could identify a therapeutic to mitigate O3-induced
susceptibility to pulmonary infections.
臭氧(O3)会导致肺损伤,加重慢性肺部疾病,并增加对呼吸道疾病的易感性。
感染.流行病学研究将空气污染暴露与呼吸道感染发病率密切相关。
感染,这是重要的,因为超过1/3的美国人口生活在地区超过
目前的O3标准。虽然O3暴露明显损害肺宿主防御,但特异性
增强呼吸道病原体易感性的分子机制仍然知之甚少。定义这些
这些机制需要将环境污染物改变的分子途径与那些对宿主至关重要的分子途径联系起来,
病原体相互作用清道夫受体家族就是这样的分子通路。在这份提案中,我们计划
研究清道夫受体CD 163在O3诱导的肺免疫改变中的作用。CD 163为B类
清道夫受体,在单核细胞和巨噬细胞上表达,存在于膜结合和
可溶性(sCD 163)形式。膜CD 163通过识别和内化清除无细胞血红蛋白(CFH)
血红蛋白-触珠蛋白复合物。一旦被CD 163识别,该复合物就被血红素加氧酶-1降解
转化为抗炎副产品延迟CFH清除增强炎症反应,加重肺
疾病,并改变巨噬细胞吞噬作用和凋亡细胞清除(巨噬细胞吞噬作用),导致
持续性炎症和病原体清除缺陷。确定CD 163在O3介导的巨噬细胞中的作用
功能可以揭示一种新的机制,介导O3引起的不良健康影响。我们的初步研究
表明在来自人受试者支气管肺泡灌洗(BAL)巨噬细胞中CD 163表达上调
实验室急性臭氧暴露支持人类数据,暴露于O3的小鼠的BAL增加
巨噬细胞CD 163表达和BALF CFH。O3暴露的CD 163缺陷小鼠显示肺
损伤、嗜中性粒细胞增多和空泡性凋亡中性粒细胞的频率。根据这些观察,我们
假设CFH巨噬细胞依赖性清除是由CD 163介导的,这是一种限制
急性肺损伤后O3,并保持有效的吞噬功能和病原体的吞噬。研究
提出将定义:1)CD 163如何通过促进红细胞增多来限制肺部炎症; 2)CD 163如何
CFH的清除维持了巨噬细胞对病原体的吞噬作用。这些研究是翻译的;整合的
鼠和人样本/观察结果。这些研究的完成将定义一种新的分子途径,
O3引起的健康影响,并定义了一个特定的机制,环境污染物介导的关键
巨噬细胞功能。此外,sCD 163的研究可以确定一种治疗方法,以减轻O3诱导的
易受肺部感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kymberly Mae Gowdy其他文献
Kymberly Mae Gowdy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kymberly Mae Gowdy', 18)}}的其他基金
Dietary DHA mitigates ozone induced pulmonary inflammation
膳食 DHA 可减轻臭氧引起的肺部炎症
- 批准号:
10360534 - 财政年份:2020
- 资助金额:
$ 60.26万 - 项目类别:
Dietary DHA mitigates ozone induced pulmonary inflammation
膳食 DHA 可减轻臭氧引起的肺部炎症
- 批准号:
10563167 - 财政年份:2020
- 资助金额:
$ 60.26万 - 项目类别:
Dietary EPA mitigates ozone induced pulmonary inflammation through ChemR23 signaling
膳食 EPA 通过 ChemR23 信号传导减轻臭氧引起的肺部炎症
- 批准号:
10506938 - 财政年份:2020
- 资助金额:
$ 60.26万 - 项目类别:
Novel role for CD163 in ozone induced alterations of pulmonary immunity
CD163 在臭氧诱导的肺免疫改变中的新作用
- 批准号:
10408766 - 财政年份:2018
- 资助金额:
$ 60.26万 - 项目类别:
Novel role for CD163 in ozone induced alterations of pulmonary immunity
CD163 在臭氧诱导的肺免疫改变中的新作用
- 批准号:
10158675 - 财政年份:2018
- 资助金额:
$ 60.26万 - 项目类别:
Novel role for CD163 in ozone induced alterations of pulmonary immunity
CD163 在臭氧诱导的肺免疫改变中的新作用
- 批准号:
9762914 - 财政年份:2018
- 资助金额:
$ 60.26万 - 项目类别:
Novel role for CD163 in ozone induced alterations of pulmonary immunity
CD163 在臭氧诱导的肺免疫改变中的新作用
- 批准号:
10290075 - 财政年份:2018
- 资助金额:
$ 60.26万 - 项目类别:
Novel role for CD163 in ozone induced alterations of pulmonary immunity
CD163 在臭氧诱导的肺免疫改变中的新作用
- 批准号:
10622014 - 财政年份:2018
- 资助金额:
$ 60.26万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
- 批准号:
MR/Y000404/1 - 财政年份:2023
- 资助金额:
$ 60.26万 - 项目类别:
Fellowship